Persistent facial erythema

Drug	Drug Name	Drug Description
DB00935	Oxymetazoline	An alpha-1A adrenoceptor agonist used to treat nasal congestion, allergic reactions of the eye, and facial erythema associated with rosacea.

Drug	Drug Name	Target	Type
DB00935	Oxymetazoline	Alpha-1A adrenergic receptor	target
DB00935	Oxymetazoline	Alpha-2A adrenergic receptor	target
DB00935	Oxymetazoline	Alpha-2C adrenergic receptor	target
DB00935	Oxymetazoline	Alpha-2B adrenergic receptor	target
DB00935	Oxymetazoline	Alpha-1B adrenergic receptor	target
DB00935	Oxymetazoline	Alpha-1D adrenergic receptor	target
DB00935	Oxymetazoline	5-hydroxytryptamine receptor 1A	target
DB00935	Oxymetazoline	5-hydroxytryptamine receptor 1B	target
DB00935	Oxymetazoline	5-hydroxytryptamine receptor 1D	target
DB00935	Oxymetazoline	5-hydroxytryptamine receptor 1C	target
DB00935	Oxymetazoline	UDP-glucuronosyltransferase 1-9	enzyme
DB00935	Oxymetazoline	Cytochrome P450 2C19	enzyme

Drug	Drug Name	Phase	Status	Count